These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 24898559

  • 1. Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride.
    Jung JY, Yeon JH, Choi JW, Kwon SH, Kim BJ, Youn SW, Park KC, Huh CH.
    Int J Dermatol; 2014 Nov; 53(11):1351-7. PubMed ID: 24898559
    [Abstract] [Full Text] [Related]

  • 2. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
    Gubelin Harcha W, Barboza Martínez J, Tsai TF, Katsuoka K, Kawashima M, Tsuboi R, Barnes A, Ferron-Brady G, Chetty D.
    J Am Acad Dermatol; 2014 Mar; 70(3):489-498.e3. PubMed ID: 24411083
    [Abstract] [Full Text] [Related]

  • 3. The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit-risk assessment of finasteride and dutasteride.
    Gupta AK, Charrette A.
    J Dermatolog Treat; 2014 Apr; 25(2):156-61. PubMed ID: 23768246
    [Abstract] [Full Text] [Related]

  • 4. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study.
    Shanshanwal SJ, Dhurat RS.
    Indian J Dermatol Venereol Leprol; 2017 Apr; 83(1):47-54. PubMed ID: 27549867
    [Abstract] [Full Text] [Related]

  • 5. Dutasteride in Androgenetic Alopecia: An Update.
    Arif T, Dorjay K, Adil M, Sami M.
    Curr Clin Pharmacol; 2017 Apr; 12(1):31-35. PubMed ID: 28294070
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia.
    Sato A, Takeda A.
    J Dermatol; 2012 Jan; 39(1):27-32. PubMed ID: 21980923
    [Abstract] [Full Text] [Related]

  • 7. The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia.
    Boersma IH, Oranje AP, Grimalt R, Iorizzo M, Piraccini BM, Verdonschot EH.
    Indian J Dermatol Venereol Leprol; 2014 Jan; 80(6):521-5. PubMed ID: 25382509
    [Abstract] [Full Text] [Related]

  • 8. Androgenetic alopecia; drug safety and therapeutic strategies.
    Motofei IG, Rowland DL, Baconi DL, Tampa M, Sârbu MI, Păunică S, Constantin VD, Bălălău C, Păunică I, Georgescu SR.
    Expert Opin Drug Saf; 2018 Apr; 17(4):407-412. PubMed ID: 29363345
    [Abstract] [Full Text] [Related]

  • 9. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.
    Olsen EA, Hordinsky M, Whiting D, Stough D, Hobbs S, Ellis ML, Wilson T, Rittmaster RS, Dutasteride Alopecia Research Team.
    J Am Acad Dermatol; 2006 Dec; 55(6):1014-23. PubMed ID: 17110217
    [Abstract] [Full Text] [Related]

  • 10. Effective treatment of female androgenic alopecia with dutasteride.
    Olszewska M, Rudnicka L.
    J Drugs Dermatol; 2005 Dec; 4(5):637-40. PubMed ID: 16167423
    [Abstract] [Full Text] [Related]

  • 11. Combination therapy with finasteride and low-dose dutasteride in the treatment of androgenetic alopecia.
    Boyapati A, Sinclair R.
    Australas J Dermatol; 2013 Feb; 54(1):49-51. PubMed ID: 22686691
    [Abstract] [Full Text] [Related]

  • 12. Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS).
    Nickel JC, Gilling P, Tammela TL, Morrill B, Wilson TH, Rittmaster RS.
    BJU Int; 2011 Aug; 108(3):388-94. PubMed ID: 21631695
    [Abstract] [Full Text] [Related]

  • 13. Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1 mg, daily.
    Price VH, Menefee E, Sanchez M, Ruane P, Kaufman KD.
    J Am Acad Dermatol; 2002 Apr; 46(4):517-23. PubMed ID: 11907500
    [Abstract] [Full Text] [Related]

  • 14. A 5-year retrospective analysis of 5α-reductase inhibitors in men with benign prostatic hyperplasia: finasteride has comparable urinary symptom efficacy and prostate volume reduction, but less sexual side effects and breast complications than dutasteride.
    Kaplan SA, Chung DE, Lee RK, Scofield S, Te AE.
    Int J Clin Pract; 2012 Nov; 66(11):1052-5. PubMed ID: 23067029
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of long-term efficacy of finasteride in Korean men with androgenetic alopecia using the basic and specific classification system.
    Shin JW, Chung EH, Kim MB, Kim TO, Kim WI, Huh CH.
    J Dermatol; 2019 Feb; 46(2):139-143. PubMed ID: 30536893
    [Abstract] [Full Text] [Related]

  • 16. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P, Srisuwanwattana P, Chalermroj N, Khunkhet S.
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [Abstract] [Full Text] [Related]

  • 17. The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis.
    Zhou Z, Song S, Gao Z, Wu J, Ma J, Cui Y.
    Clin Interv Aging; 2019 Dec; 14():399-406. PubMed ID: 30863034
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic experience with oral finasteride for androgenetic alopecia in female-to-male transgender patients.
    Moreno-Arrones OM, Becerra A, Vano-Galvan S.
    Clin Exp Dermatol; 2017 Oct; 42(7):743-748. PubMed ID: 28691187
    [Abstract] [Full Text] [Related]

  • 19. Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia.
    Gupta AK, Talukder M, Williams G.
    J Dermatolog Treat; 2022 Nov; 33(7):2946-2962. PubMed ID: 35920739
    [Abstract] [Full Text] [Related]

  • 20. Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis.
    Lee S, Lee YB, Choe SJ, Lee WS.
    Acta Derm Venereol; 2019 Jan 01; 99(1):12-17. PubMed ID: 30206635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.